Associated Papers
Source, co-occurrence, and prognostic value of PTEN mutations or loss in colorectal cancer.
Serebriiskii IG et al.
Npj Genomic Medicine, 2023
38001126 (PubMed )
Supplement: 41525_2023_384_MOESM1_ESM.xlsx › Table_S8
Getting under the skin: The role of CDK4/6 in melanomas.
Guo L et al.
European Journal of Medicinal Chemistry, 2020
CDKN2A Polymorphism in Melanoma Patients in Colombian Population: A Case-Control Study.
Tovar-Parra JD et al.
Biomed Research International, 2020
Identification of MET and SRC activation in melanoma cell lines showing primary resistance to PLX4032.
Vergani E et al.
Neoplasia (new York, N.y.), 2011
Somatic alterations in the melanoma genome: a high-resolution array-based comparative genomic hybridization study.
Gast A et al.
Genes, Chromosomes & Cancer, 2010
Genetic variation and the mitogen-activated protein kinase (MAPK) signaling pathway.
Cho S et al.
Omics : a Journal of Integrative Biology, 2006
BRAF alterations are associated with complex mutational profiles in malignant melanoma.
Daniotti M et al.
Oncogene, 2004
Select a paper to view details